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Abstract—The utilization of mobile technology in the field of
medicine and healthcare has become a decisive aspect. The entire
field is denoted as mobile health (mHealth). For mHealth, the
development and use of mobile applications are crucial. The
purposes and goals of mHealth apps, in turn, are manifold. As
a consequence, a plethora of mHealth apps can be found in
the app stores. Interestingly, for patients, users, and health care
providers that consider to use mHealth apps one aspect has been
less pursued so far: Systematic and standardized ways that help
about the quality of an app or its medical evidence are mainly
missing. The Mobile App Rating Scale (MARS) is a standardized
instrument that aims at the systematic and comparable evaluation
of the quality of mobile health apps as well as categorizing their
goals and functions. It comprises 23 items, which are utilized to
calculate a rating scale. Having MARS in mind, a database was
developed that is called Mobile Health App Database (MHAD).
The latter offers technical features to systematically utilize the
MARS for researchers as well as clinicians and end-users that
(i) want to evaluate apps as well as (ii) want an interactive and
easy-to-use web interface that shows the results of the rating
procedure. MHAD comprises a rating platform that supports
the conduction of MARS ratings and their release process. With
the information platform, a web application was developed that
prepares the data stored in the rating platform for being freely
viewed and studied by users, patients, and health care providers.
The goal of MHAD constitutes to be an open science repository
that encourages researchers to release their MARS ratings to
a broader audience. Such repositories become more and more
important in many fields, especially in the field of mHealth.
Index Terms—mHealth; mobile health; Mobile App Rating
Scale; MARS; app quality; medical database
I. INTRODUCTION
Mobile apps and their data collection capabilities are only
one direction that has garnered a lot of attention in the last
years [1]. Especially in healthcare and medicine, mobile apps
are a basis for new data sources and medical insights [2]–
[4]. In addition to the sophisticated collection possibilities of
data, mobile apps can be utilized to guide and inform patients
about health conditions and questions as well as health-related
day-by-day issues [5], [6]. Interestingly, both in research and
industry, less efforts have been undertaken to evaluate the
quality and evidence of mobile health apps. When monitoring
the field of mHealth in the major app stores (i.e., Apple App
Store, Google Play Store), it can be observed that currently
over 300,000 apps are available, with over 200 additional
apps being added on a daily basis [7], [8]. Although the
dramatic increase of mobile health apps is ongoing, efforts
to systematically evaluate them are still rare. From a broader
perspective, the following aspects are particularly apparent at
the moment:
1) Although recent regulations (e.g., the General Data Pro-
tection Regulation or the Medical Device Regulation in
the EU) have been pursued to guide and protect users in
the digital world better, no general standards in terms
of quality have been presented for mHealth apps so far.
2) The number of users that will utilize mHealth apps will
constantly increase [9]. Hence, the demands of the users
for offered apps increase in the same magnitude of orders.
Therefore, mHealth apps are introduced in a way that
makes it very complex for interested stakeholders to
reliably decide which app shall be used.
3) The development of mobile apps in general and for
mHealth in particular is technically challenging due to
the frequent update cycles of the mobile operating system
vendors and the associated API changes. This includes the
frequent hardware advancements of smart mobile devices
(e.g., sensor features are offered with a new smartphone
version).
4) For the quality as well as for the evidence, still less
instruments exist that provide guidance in the jungle of
offered and newly introduced mHealth apps.
Some tools were developed for the systematic evalua-
tion of the quality of mHealth apps. For example, the app
evaluation model of the American Psychological Association
[10], the Evaluation Tool for Mobile and Web-Based eHealth
Interventions (ENLIGHT) [11], [12], or the Mobile App
Rating Scale (MARS) [13]. The MARS [13] is an instrument
based on 23 items, which provides standardized expert ratings
of mobile health apps.
The items were developed based on an intensive literature
study and evaluation of existing apps. The instrument revealed
to be reliable in evaluating mHealth apps (i.e., in terms of
internal consistency, inter-rater reliability and confirmatory
factor analysis of its structure [14]). Notably, MARS has a
global score based on the following subscales: engagement,
functionality, aesthetics and information quality. In addition,
there is a subjective quality section, a perceived impact section
and a classification section for the theoretical background and
the app functionality.
As the MARS has proven its feasibility and psychometric
quality in existing works and evaluations [14]–[16], the authors
of the current work decided to develop a database solution that
shall support making the MARS expert ratings for mHealth
apps available to the public more easily and comprehensively.
This is necessary, since consumers are particularly vulnerable
right now, since the mHealth market is not well regulated
and most of the currently available mHealth apps are not
scientifically evaluated [15]–[17]. Thus, there is an urgent
need to inform users, patients, and healthcare providers about
the quality of mHealth apps [17]. The project presented in
the paper at hand is called Mobile Health App Database1
(MHAD) and is online since the end of 2018 and currently
comprises MARS ratings of 1112 mHealth apps (see Fig. 1),
stemming from nine categories; i.e., mindfulness, anxiety,
depression, support children and young people, cancer, PTSD,
pain, support the elderly, and sports.
Technically, MHAD consists of a powerful rating platform
to manage MARS ratings as well as an information platform1.
The work at hand delineates the important requirements of
MHAD, its technical features, as well as its use in practice.
In particular, it will be shown how the technical procedure
from obtaining relevant apps from the apps stores up to their
rating release on the information platform was conceived and
implemented. As less comparable solutions exist, the MHAD
repository shall help to release results of instruments like
the MARS for the overall guidance of users, patients, and
healthcare providers in the jungle of mHealth apps more
efficiently and systematically.
The remainder of this work is organized as follows. In
Section II, related works are discussed. As MHAD is based
on MARS, the latter is presented in more detail in Section III.
Based on this, Section IV discusses the overall concept of
MHAD. In particular, it is shown how the flow of the overall
rating procedure was chosen. The technical requirements that
are addressed will be discussed in Section V, while Section VI
presents a selected choice of impressions of the platform
and how the technical requirements have been implemented.
In addition, this section discusses the current statistics of
the platform. Finally, Section VII summarizes this work and
provides an outlook on future work.
II. RELATED WORK
Three kinds of related research are relevant in the scope
of this paper. First, Internet-based platforms that offer guid-
1MHAD information platform: www.mhad.science
Fig. 1. Screenshot: the category filter function.
ance for mHealth apps. Second, approaches that deal with
the quality and evidence of mHealth apps. Third, general
considerations on the use of mHealth apps by researchers
and institutions. Regarding the first category relevant for
the work at hand, several other platform exist. In Germany,
three other platforms are prominent [18]–[20]. In contrast to
these platforms, MHAD is the only one that is based on a
standardized and scientifically proven instrument. In addition,
the mentioned other platforms use their own criteria for the
evaluation of mHealth apps. In research, also works can be
found that establish database sources for the evaluation of
mHealth apps. For example, the authors of [21] have made
their data source of the paper available for other researchers.
However, they only provide the crawled app store information
and not calculated results. Regarding the second category,
summaries that can be used as a very good starting point
can be found in [22]–[24] or works that address particular
aspects [25]–[27] or the development of rating tools [28],
[29]. Furthermore, works can be found that deal with the user-
friendly development of mHealth apps, thus increasing their
quality by design [30]–[32]. Research that are utilizing the
MARS are also all in this second category [16], [33], [34].
The number of works based on the MARS show its general
applicability. Related to MARS, other established instruments
(e.g., from the computer science field) have been adjusted to
rate the quality of mHealth apps [11], [35], [36]. It should
however be kept in mind that the latter instruments cannot
replace controlled trials. Only rigorously tested mHealth apps
can be described as evidence-based. The MARS includes an
item in the information quality scale regarding evidence-base
of the app. In general, the evidence-base of most of the
mHealth apps is low at the moment [14], [37], [38]. Regarding
the third category, on the European level, for example, first
considerations were done very early (e.g., [39]). Also in
the USA, such regulations were released very early [40].
Recently, in Germany, a new recommendation was released
[41]. Moreover, quality criteria based on existing models for
the systematic assessment of telemedicine applications were
suggested by researchers for Internet-based and mobile mental
health interventions [42]. Altogether, for all existing works,
to the best of the authors knowledge, MHAD is the biggest
platform for mHealth apps using a reliable instrument of high
psychometric quality. However, also many related works have
to be mentioned, the goals partly differ significantly. This
is especially the case for the third category. However, these
works must be considered for platforms like MHAD.
III. MARS BACKGROUND INFORMATION
As already introduced, the MARS was developed as an
instrument to efficiently and reliably classify and assess the
quality of mHealth apps [13]. It comprises five categories:
engagement, functionality, aesthetics, information quality, and
subjective quality. These categories were extracted and se-
lected based on 372 criteria from 25 published papers. This
emphasizes the broad perspective of the MARS. Note that the
general quality rating for the 23 items utilizes the following
5-point scale: (1) inadequate (2) poor (3) acceptable (4) good
(5) excellent.
For MHAD, the MARS-G is utilized [34]. It is a German
translation of the original MARS and was developed by the
authorization and help of the MARS authors. As the original
version, the MARS-G, has the four sections engagement,
functionality, aesthetics and information quality (see Table I,
A-D). Based on the latter, a global scale can be calculated.
It also has the subjective quality section and the perceived
impact section like the original MARS (see Table I, E&F).
One more section was added to the MARS-G that is not part
of the original version, i.e., a therapeutic gain section (see
Table I, PT) to evaluate the usefulness of the mHealth app
in psychotherapy. To obtain MARS ratings for MHAD the
following procedure is applied: Two independent raters that
are trained in MARS-G (including an online training [43]) and
supervised (if necessary) by a licensed healthcare specialist
(e.g., licensed psychotherapist) perform the MARS-G ratings
on apps that shall be evaluated. Their individual MARS ratings
are summarized to final MARS scores for an evaluated app.
On the MHAD website, the global MARS score as well as the
scores of the four MARS subscales are displayed.
IV. MOBILE HEALTH APP DATABASE APPROACH
In this section, the overall procedure to accomplish the
rating process, which was introduced in the last section, is
presented and discussed, while in the next section, the concrete
technical features and their implementation are presented. In
Fig. 2, the phases and their sequence are illustrated.
In the Identification Phase, an app store crawler was
implemented for the two major app stores, i.e., the Apple
App Store and the Google Play Store. In addition, the im-
plementation and maintenance of the crawler is challenging
because, for example, the Play Store provides no official API
and its website is changed frequently by Google. However, the
development is a decisive pillar of the entire solution. If the
TABLE I
MARS-G: SECTIONS AND ITEMS
Section Title Items
A Engagement fun, interest, individual adaptability, interactivity, target group
B Functionality performance, usability, navigation, gestural design
C Aesthetics layout, graphics, visual appeal
D Information
Quality
accuracy of app description, goals, quality of information,




gain for patients, gain for therapists, risks and side effects,
ease of implementation into routine healthcare
E Subjective
Quality




awareness, knowledge, attitudes, intention to change, help
seeking, behavioral change
crawler would not exist, a manual procedure would become
necessary. As thousands of apps could be relevant, such
procedure is less feasible. Note that we implemented filtering
techniques for the crawler, so that, for example, only sports
apps are found. The technical obstacles for such a crawler
are also one more reason why only the two predominant app
stores are currently provided.
Then, in the next phase, which is denoted with Screening,
it is decided which apps that the crawler found are actually
rated. As the crawler uses the information that the app devel-
opers have provided in the stores, it might happen that these
information do not fit to the criteria that were chosen for a
rating (e.g., the category). Therefore, this screening is done
for each identified app manually.
Afterwards, in the Reviewing phase, the remaining list of
mobile apps is rated with the MARS by the reviewers. Due
to the lack of space, not all features that are provided for the
distribution can be discussed in detail. However, to mention
one example, reviewers see their assigned apps in the rating
platform, but it is possible to decline MARS ratings if a
reviewer feels not comfortable or has not the time for a rating
at the moment. By providing such features, MHAD must keep
track that always two reviewers provide a result in time.
Finally, in the Presentation Phase, the ratings are released
to the information platform. For the two phases Screening and
Reviewing, a further aspect has to be briefly discussed. In the
first technical stage of the MHAD solution, these phases were
not technically supported (i.e., rating platform features weren’t
provided). Thus, for some app ratings of the information
platform, these two phase were accomplished solely manually
(i.e., using Excel and paper-based MARS-G questionnaires).
For this manual process, MHAD provides an sophisticated
import mechanism for Excel files that is able to manage the
release procedure. As this manual procedure was very time-
consuming, the current implementation of MHAD provides
required functions for all of the four shown phases in Fig. 2.
During the course of running MHAD, more features emerged
that should be implemented. The complete list is therefore
discussed and presented in the next two sections.
Fig. 2. Mobile Health App Database (MHAD) approach at a glance.
V. TECHNICAL REQUIREMENTS
The entire MHAD endeavor started in 2018 and was initially
intended to be a dynamic website displaying apps that were
rated based on the MARS. After starting with the rating of apps,
mainly based on pen-and-paper, many issues emerged that lead
to the current development stage of MHAD. For example, it
quickly emerged that a powerful platform is needed to manage
the entire review and release process. With having a rating
platform in mind, the idea came up to manage also dynamic
content for the MHAD information platform. Following this
history, a modular crawler component providing a RESTful
API, a rating platform, and an information platform were
conceived and implemented. Table II summarizes all require-
ments at a glance. Only one selected feature is further dis-
cussed, the management of groups. It emerged that it is helpful
to assign reviews to groups of users instead of single users.
This approach has advantages and technical drawbacks. The
advantage is to better address the preferences of users to rate
particular app categories or apps with particular characteristics.
On the other, from a technical perspective, the management of
groups harbors the risk of further considerations. For example,
if assigning reviews to groups could purport that nothing has to
be monitored as there should be always someone in a group
that certainly takes over a review. Such situations must be
therefore handled through proper monitoring features. Current
considerations follow the idea of an open rating platform, like
the review process of scientific publications.
VI. MHAD IN PRACTICE
This section illustrates selected features of MHAD. First of
all, some statistics are briefly mentioned. Currently, MHAD
comprises freely available ratings of 1112 apps. That means,
for all of the 1112 apps, the procedure including two reviewers
(as described above or in [16]) for the final rating was accom-
plished. These ratings are categorized – as already mentioned
– with the following numbers for each category maintained
so far: mindfulness: 192, anxiety: 104, depression: 39, sup-
port children and young people: 13, cancer: 75, PTSD: 82,
pain: 218, support the elderly: 77 and sports: 312.
TABLE II
FUNCTIONAL REQUIREMENTS OF THE MOBILE HEALTH APP DATABASE
No Title Description
Crawler
1 Scrape Play Store The crawler enables authorized users to gather
data from the Google Play Store.
2 Scrape App Store The crawler enables authorized users to gather
data from the Apple App Store.
Rating Platform
3 App Search Feature Two search features are provided. First, the
crawler can be used to scrape the app stores.
Second, scraping results can be stored in the
internal database and scanned.
4 App Management Found and stored apps can be managed (deleted,
attributes changes, etc.).
5 Category Management Features are provided to put apps into categories.
This information, in turn, is utilized for the infor-
mation platform to show the apps in categories.
6 Dynamic Questionnaire
Views
Questionnaire input structures (e.g., for MARS-G)
can be managed and dynamically rendered.
7 Review Management Features are provided to manage reviewers, re-
views, and the release of reviewed apps.
8 User and Group Manage-
ment
Features are provided to manage users and also
to manage groups. Users can be grouped. This
feature is used with respect to the better grant of
rights as well as to assign reviews to entire groups.
The latter shall ease the review management.
9 Export Feature Features to export data (e.g., all stored apps.)
Information Platform
10 App Information Feature A feature is provided that displays all created app
information as well as the ratings information.
11 Category Feature App categories from the rating platform are uti-
lized and presented. More specifically, apps can




A content management module was implemented




Currently, a search feature is under development,
which shall enable the website users to find ratings
of particular apps more easily.
New categories and ratings are currently in preparation.
In the following, selected features presented in Table II will
be briefly introduced. As the most important feature, Fig. 4
display the three tabs that are maintained for each app. In
Fig. 4 (top), the final result of the Pacifica - Stress & Anxiety
app [44] is shown, which is 4.5. Fig. 4 (middle), in turn,
Fig. 3. Screenshots: Manage app information and its reviews (left) and MARS-G reviewer view (right).
shows the second tab, the ratings for the four MARS subscales
engagement, functionality, aesthetics, and information quality.
The third tab finally shows the app classification information,
here shown in Fig. 4 (bottom). The three latter figures have
shown information platform features. This is supplemented
by Fig. 1, which shows a screen that enables users to filter
apps based on their category. The remaining two screenshots
show rating platform features. In Fig. 3 (left), the app view
is shown. As can be obtained, the gathered information can
be edited or the app can be assigned to reviewers. Finally,
Fig. 3 (right) shows a part of the MARS-G questionnaire
and how it is displayed to a reviewer. As can be further
obtained by the menu shown in Fig. 3, the rating platform
currently summarizes features on: Reviews, Searches, Apps,
Users, Groups, and Categories.
VII. SUMMARY AND OUTLOOK
This work has presented the Mobile Health App Database
(MHAD) project, its background information as well as its
use in practice. The overarching goal of MHAD is to provide
a guide for users, patients, and health care providers regarding
the quality of mHealth apps. As the market of mHealth apps
is currently challenging to overlook and the ratings of apps in
the app stores are not based on scientific instruments, solutions
like MHAD can contribute to help various stakeholders in find-
ing suitable apps for a healthcare question. Therefore, MHAD
was conceived and implemented. The application of the MARS
rating to systematically assess the quality of mHealth apps
is time-consuming and challenging. For example, it must
be determined how new releases of already rated apps are
handled. Beyond this untackled aspect in MHAD, many more
limitations could be mentioned, including the lack of evidence-
based studies. However, MHAD is a first starting point to guide
interested stakeholders in the field of mHealth apps based
on qualified ratings. To conclude, many more goals must be
addressed in future work.
Fig. 4. Screenshot: Basic app information & overall app rating (top), detailed
MARS rating results (middle) and app classification information (bottom).
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